The annual Molecular Medicine Tri-Conference has become one of the world’s leading international events in the field of drug discovery, development and diagnostics. The Tri-Conference unites an ecosystem of 3,700 innovative thinkers and thought leaders throughout biotech, pharma and academia from around the world.
As a premier sponsor of Molecular Med Tri-Con 2017, XIFIN participated in the exhibit hall for the main conference and also the following sessions.
Improving Patient Care Through a Diagnostic Collaboration Workflow
Chrystal Adams, AVP, Product Line Management, Product Marketing, XIFIN, Inc.
Main Conference Co-Presentation with David S. McClintock, MD, Medical Director, Pathology Informatics, University of Chicago
Monday, February 20, 2017
Novel Diagnostic Technologies: Coverage Today and Coverage in the Future
Kyle Fetter, VP & General Manager, Diagnostic Services Operations, MDx Support Services, XIFIN, Inc.
Presentation during Symposia
Thursday, February 23, 2017
Cambridge Healthtech Institute (CHI) a division of Cambridge Innovation Institute is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Cambridge Marketing Consultants, Barnett International, Cambridge Meeting Planners and Healthtech Publishing, which includes Bio-IT World, Clinical Informatics News and Diagnostics World.